Aprea Therapeutics (APRE) Misses Q1 EPS by 22c

Aprea Therapeutics (NASDAQ: APRE) reported Q1 EPS of ($0.22).

For earnings history and earnings-related data on Aprea Therapeutics (APRE) click here.

You May Also Be Interested In

• Citigroup set to join top banks in Anthropic IPO - Bloomberg
• Jefferies Downgrades Pop Mart International Group Ltd (9992:HK) to Hold
• Deere shares climb as fiscal Q3 earnings and revenue top estimates